Drug profile · INN
raltitrexed
TOMUDEX
raltitrexed (TOMUDEX) is a thymidylate synthase inhibitor. Associated with Pfizer Australia Pty Ltd.
TGA: approved NMPA: clinical trials
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — raltitrexed
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.81
Quick answer
raltitrexed (TOMUDEX) is a thymidylate synthase inhibitor. Associated with Pfizer Australia Pty Ltd.
Key facts
INN raltitrexed
Brand TOMUDEX
Mechanism Thymidylate synthase inhibitor
Target Thymidylate synthase
Originator Pfizer Australia Pty Ltd
Mechanism of action
Thymidylate synthase inhibitor
Primary target: Thymidylate synthase
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is raltitrexed?
raltitrexed (TOMUDEX) is a thymidylate synthase inhibitor. Associated with Pfizer Australia Pty Ltd.
What is the brand name for raltitrexed?
TOMUDEX is a marketed brand name for raltitrexed. Check FDA Drugs@FDA for the current US label holder and prescribing information.